+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stem Cell Banking Market - Global Forecast 2026-2032- Product Image
Stem Cell Banking Market - Global Forecast 2026-2032- Product Image
Sale

Stem Cell Banking Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012128
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Stem Cell Banking Market is projected to reach USD 11.22 Billion in 2026. It is expected to continue growing at a CAGR of 9.68%, reaching USD 19.74 Billion by 2032.

Stem cell banking has evolved from a niche newborn cord blood preservation service into a strategic biobanking infrastructure supporting hematopoietic stem cell transplantation, regenerative medicine research, cell therapy manufacturing, and precision medicine. Demand is supported by the established clinical use of hematopoietic stem cells for blood cancers, immune deficiencies, inherited metabolic disorders, and bone marrow failure syndromes, while validated research in mesenchymal stromal cells, induced pluripotent stem cells, and tissue-derived cells is expanding the long-term value proposition.

The stem cell banking market is shaped by rigorous quality requirements, including donor consent, chain-of-custody controls, infectious disease testing, HLA typing, cryopreservation validation, and end-to-end traceability. Accredited public banks, private family banks, hospital systems, fertility networks, and cell therapy service providers are competing and collaborating to convert high-quality biological samples into clinically usable assets. For industry leaders, the decisive opportunity is no longer storage volume alone; it is the ability to deliver compliant, diverse, searchable, and therapy-ready stem cell inventories.

Transformative Shifts in the Stem Cell Banking Landscape

The stem cell banking landscape is shifting from passive storage to integrated, quality-assured biorepository ecosystems. Public cord blood banks continue to prioritize allogeneic transplantation access and HLA diversity, while private banks are repositioning around family health, newborn biological preservation, and potential future applications. Hybrid models are gaining attention because they can support public health needs while improving consumer engagement and commercial sustainability.

Regulatory scrutiny is also rising. In the United States, human cells, tissues, and cellular and tissue-based products are governed under FDA rules such as 21 CFR Part 1271, while the European framework includes tissue and cell quality, safety, and advanced therapy medicinal product requirements. Accreditation from recognized bodies such as AABB and FACT-NetCord is becoming a competitive differentiator. At the operational level, automation, closed-system processing, digital sample tracking, vapor-phase liquid nitrogen storage, and validated thawing protocols are becoming essential to reduce contamination risk and protect cell viability.

Cumulative Impact of Artificial Intelligence on Stem Cell Banking

Artificial intelligence is beginning to create cumulative value across stem cell banking by improving donor-unit search, inventory prioritization, viability forecasting, quality control, and logistics. AI-enabled analytics can support HLA matching workflows, flag incomplete records, identify high-value units based on cell dose and match probability, and optimize storage utilization. In laboratories, machine vision and predictive analytics can help standardize cell counting, colony assessment, and deviation detection when validated against regulated quality systems.

The impact is strongest when AI is paired with interoperable data architecture, standardized metadata, and audit-ready governance. Because stem cell banking operates in regulated healthcare environments, AI outputs must remain explainable, validated, and human-supervised. Leaders that invest in secure data lakes, consent-aware analytics, cybersecurity, and privacy-preserving methods will be better positioned to connect banked samples with clinical trials, transplantation networks, and cell therapy manufacturers without compromising donor rights or regulatory compliance.

Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East & Africa

Asia-Pacific is one of the most dynamic regions for stem cell banking, supported by large birth cohorts, expanding private healthcare access, government-backed biotechnology strategies, and strong clinical research activity across China, India, Japan, South Korea, Singapore, and Australia. The region combines rising consumer awareness with growing hospital-based cell therapy infrastructure, although standards, reimbursement pathways, and regulatory enforcement vary significantly by country.

North America remains a mature and innovation-led region, anchored by FDA oversight in the United States, Health Canada regulation, established public and private cord blood banks, major transplant centers, and a deep regenerative medicine pipeline. Europe benefits from harmonized tissue and cell safety expectations, GDPR-driven data governance, advanced hospital networks, and cross-border clinical research collaboration, while Latin America is gradually expanding through Brazil and Mexico as healthcare modernization, private banking awareness, and laboratory capacity improve.

The Middle East is investing in medical tourism, precision medicine, transplant services, and national health infrastructure, with GCC countries showing the strongest institutional momentum. Africa remains underpenetrated but strategically important because genetically diverse stem cell inventories can improve donor match availability for populations that are historically underrepresented in global registries and transplantation networks.

Group Insights: ASEAN, GCC, European Union, BRICS, G7 & NATO

ASEAN markets are advancing through fertility services, private hospital growth, medical tourism, and government biotechnology initiatives, with Singapore serving as a regional quality, clinical research, and bioprocessing hub. The GCC is building stem cell banking capacity through sovereign healthcare investment, transplant program development, precision medicine initiatives, and demand for advanced private healthcare services, particularly in Saudi Arabia, the United Arab Emirates, and Qatar.

The European Union provides one of the most structured environments for stem cell banking because tissue safety rules, clinical trial regulation, advanced therapy medicinal product oversight, and data protection requirements create a strong compliance baseline. BRICS countries represent a strategically important opportunity due to large populations, expanding biomanufacturing capacity, rising regenerative medicine investment, and growing demand for domestic healthcare innovation, although policy consistency and enforcement differ across members.

G7 countries lead in clinical research, accreditation adoption, transplant infrastructure, and commercialization of cell-based therapies. NATO members, especially those overlapping with North America and Europe, benefit from advanced biomedical research funding, resilient cold-chain systems, health security planning, and coordinated medical infrastructure priorities that reinforce the value of validated biobanking.

Country Insights Across Major Stem Cell Banking Markets

The United States leads in private cord blood banking, transplant infrastructure, clinical trials, FDA-regulated cell therapy development, and commercialization of advanced cellular medicines, while Canada combines strong public health governance with reputable research hospitals, national donor systems, and regulated tissue establishment practices. Mexico and Brazil are important Latin American markets, supported by private healthcare demand, improving laboratory capacity, growing maternal health engagement, and increasing awareness of newborn stem cell preservation.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain advanced transplantation networks and regulated tissue banking systems, with Germany and France standing out for biomedical manufacturing depth, hospital infrastructure, and clinical research scale. Russia has scientific capability, domestic demand, and academic expertise in cell biology, although market development is shaped by regulatory complexity, funding constraints, and geopolitical conditions.

In Asia-Pacific, China and India offer large addressable populations, expanding hospital networks, and fast-growing biotechnology ecosystems; Japan benefits from an established regenerative medicine framework and advanced clinical infrastructure; South Korea is strong in cell therapy innovation, bioprocessing, and translational research; and Australia combines high regulatory standards with active clinical research, public banking infrastructure, and established transplantation capability.

Actionable Recommendations for Stem Cell Banking Leaders

Industry leaders should prioritize accredited quality systems, transparent consent, and clinically meaningful inventory management over volume-driven collection strategies. Investments in AABB- or FACT-NetCord-aligned processes, validated cryopreservation, automated tracking, environmental monitoring, and robust release testing can improve trust among clinicians, regulators, and families.

Banks should build partnerships with maternity hospitals, transplant centers, fertility clinics, academic research institutions, and cell therapy developers. Strategic value will come from connecting stored units to real clinical and research demand through HLA diversity programs, searchable digital inventories, compliant data-sharing, and trial-ready sample documentation. Leaders should also implement AI governance, cybersecurity controls, and privacy-by-design systems before scaling predictive analytics.

Research Methodology

The executive summary is developed using a structured market research approach that combines regulatory review, clinical practice assessment, technology trend analysis, and regional benchmarking. Key evidence inputs include established transplantation use cases, tissue and cell banking standards, cell therapy regulatory pathways, accreditation expectations, cryopreservation practices, and observable investment patterns across healthcare and biotechnology ecosystems.

The methodology emphasizes triangulation across primary industry signals, secondary public-domain information, policy frameworks, clinical infrastructure indicators, accreditation requirements, and scientific literature. Market interpretation focuses on verified drivers such as cord blood transplantation, HLA matching needs, biobank quality controls, regenerative medicine pipelines, and the operational requirements of cryogenic storage, traceability, chain-of-custody management, and consent-based data governance.

Conclusion

Stem cell banking is entering a more sophisticated phase in which value is defined by quality, compliance, data integrity, donor diversity, and clinical connectivity. While cord blood preservation remains the foundation of the market, future competitive strength will be influenced by cell therapy manufacturing readiness, regenerative medicine trials, AI-enabled inventory intelligence, and broader use of biobanks in precision healthcare.

Organizations that combine scientific credibility with transparent consumer education, rigorous quality systems, and strategic clinical partnerships will be best positioned to succeed. The most competitive stem cell banks will operate not simply as storage providers, but as trusted biological infrastructure partners for transplantation, research, and next-generation cellular medicine.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Stem Cell Banking Market, by Tissue Source
7.1. Introduction
7.2. Adipose Tissue
7.3. Bone Marrow
7.4. Cord Tissue
7.5. Peripheral Blood
7.6. Umbilical Cord Blood
8. Stem Cell Banking Market, by Cell Type
8.1. Introduction
8.2. Embryonic Stem Cell
8.3. Hematopoietic Stem Cell
8.4. Induced Pluripotent Stem Cell
8.5. Mesenchymal Stem Cell
9. Stem Cell Banking Market, by Service Type
9.1. Introduction
9.2. Collection
9.2.1. Clinic Collection
9.2.2. Home Collection
9.3. Distribution
9.3.1. Courier Service
9.3.2. Third Party Logistics
9.4. Processing
9.4.1. Automated Processing
9.4.2. Manual Processing
9.5. Storage
9.5.1. Liquid Phase
9.5.2. Mechanical Refrigeration
9.5.3. Vapor Phase
9.6. Thawing
9.6.1. Automated Thawing
9.6.2. Manual Thawing
10. Stem Cell Banking Market, by Application
10.1. Introduction
10.2. Cosmetic
10.3. Diagnostics
10.4. Drug Discovery
10.5. Research
10.6. Therapeutic
11. Stem Cell Banking Market, by Ownership Model
11.1. Introduction
11.2. Hybrid
11.3. Private
11.4. Public
12. Stem Cell Banking Market, by End User
12.1. Introduction
12.2. Diagnostic Laboratories
12.3. Hospitals
12.4. Pharmaceutical & Biotechnology Companies
12.5. Research Institutes
12.6. Specialty Clinics
13. Stem Cell Banking Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Stem Cell Banking Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Stem Cell Banking Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. America Cell Bank
17.2. Amgen Inc.
17.3. AstraZeneca PLC
17.4. BeiGene, Ltd.
17.5. Bio-Techne Corporation
17.6. BIONET Corp.
17.7. BioVault Technical Ltd.
17.8. Cellaviva AB
17.9. Celularity Inc.
17.10. Cordlife Group Limited
17.11. Cryoviva Biotech India Pvt. Ltd.
17.12. FamiCord Group
17.13. Gilead Sciences, Inc.
17.14. Global Cord Blood Corporation
17.15. LifeCell International Pvt. Ltd.
17.16. Macopharma SA
17.17. Pharmicell Co., Ltd.
17.18. Ree Laboratories Pvt. Ltd.
17.19. Sanofi S.A.
17.20. STARLIMS Corporation
17.21. StemCell Institute, Inc.
17.22. StemCord Private Ltd.
17.23. StemCyte India Therapeutics Pvt. Ltd.
17.24. Thermo Fisher Scientific Inc.
17.25. ThermoGenesis Holdings, Inc.
17.26. Vertex Pharmaceuticals Incorporated
17.27. Viacord, Inc.
17.28. Vita 34 AG
List of Figures
FIGURE 1. GLOBAL STEM CELL BANKING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL STEM CELL BANKING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL STEM CELL BANKING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL STEM CELL BANKING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL STEM CELL BANKING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL STEM CELL BANKING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL STEM CELL BANKING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL STEM CELL BANKING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL STEM CELL BANKING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL STEM CELL BANKING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL STEM CELL BANKING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL STEM CELL BANKING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL STEM CELL BANKING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL STEM CELL BANKING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL STEM CELL BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ADIPOSE TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ADIPOSE TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ADIPOSE TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BONE MARROW MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BONE MARROW MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BONE MARROW MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL CORD TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL CORD TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL CORD TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PERIPHERAL BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PERIPHERAL BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PERIPHERAL BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL UMBILICAL CORD BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL UMBILICAL CORD BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL UMBILICAL CORD BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL EMBRYONIC STEM CELL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL EMBRYONIC STEM CELL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL EMBRYONIC STEM CELL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL HEMATOPOIETIC STEM CELL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL HEMATOPOIETIC STEM CELL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL HEMATOPOIETIC STEM CELL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MESENCHYMAL STEM CELL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MESENCHYMAL STEM CELL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL MESENCHYMAL STEM CELL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL COLLECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL COLLECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL COLLECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CLINIC COLLECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CLINIC COLLECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CLINIC COLLECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL HOME COLLECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL HOME COLLECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL HOME COLLECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL DISTRIBUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL DISTRIBUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL DISTRIBUTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL COURIER SERVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL COURIER SERVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL COURIER SERVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL THIRD PARTY LOGISTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL AUTOMATED PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL AUTOMATED PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL AUTOMATED PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL MANUAL PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL MANUAL PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MANUAL PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL STORAGE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL STORAGE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL STORAGE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL LIQUID PHASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL LIQUID PHASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL LIQUID PHASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MECHANICAL REFRIGERATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MECHANICAL REFRIGERATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MECHANICAL REFRIGERATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL VAPOR PHASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL VAPOR PHASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL VAPOR PHASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL THAWING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL THAWING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL THAWING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL AUTOMATED THAWING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL AUTOMATED THAWING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL AUTOMATED THAWING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL MANUAL THAWING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL MANUAL THAWING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL MANUAL THAWING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL COSMETIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL COSMETIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL COSMETIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL HYBRID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL HYBRID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL HYBRID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL STEM CELL BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. EUROPE STEM CELL BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. EUROPE STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 162. EUROPE STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 163. EUROPE STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 164. EUROPE STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 165. EUROPE STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 166. EUROPE STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 167. EUROPE STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 168. EUROPE STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 169. EUROPE STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 170. EUROPE STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 171. EUROPE STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. AFRICA STEM CELL BANKING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. AFRICA STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 186. AFRICA STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 187. AFRICA STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 188. AFRICA STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 189. AFRICA STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 190. AFRICA STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 191. AFRICA STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 192. AFRICA STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 193. AFRICA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 194. AFRICA STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 195. AFRICA STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 196. GLOBAL STEM CELL BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 197. ASEAN STEM CELL BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 198. ASEAN STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 199. ASEAN STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 200. ASEAN STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 201. ASEAN STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 202. ASEAN STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 203. ASEAN STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 204. ASEAN STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 205. ASEAN STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 206. ASEAN STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 207. ASEAN STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 208. ASEAN STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 209. GCC STEM CELL BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 210. GCC STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 211. GCC STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 212. GCC STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 213. GCC STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 214. GCC STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 215. GCC STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 216. GCC STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 217. GCC STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 218. GCC STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 219. GCC STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 220. GCC STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 233. BRICS STEM CELL BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 234. BRICS STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 235. BRICS STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 236. BRICS STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 237. BRICS STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 238. BRICS STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 239. BRICS STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 240. BRICS STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 241. BRICS STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 242. BRICS STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 243. BRICS STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 244. BRICS STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. G7 STEM CELL BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 246. G7 STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 247. G7 STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 248. G7 STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 249. G7 STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 250. G7 STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 251. G7 STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 252. G7 STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 253. G7 STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 254. G7 STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 255. G7 STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 256. G7 STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 257. NATO STEM CELL BANKING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 258. NATO STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 259. NATO STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 260. NATO STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 261. NATO STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 262. NATO STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 263. NATO STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 264. NATO STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 265. NATO STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 266. NATO STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 267. NATO STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 268. NATO STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 269. GLOBAL STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 270. UNITED STATES STEM CELL BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. UNITED STATES STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 272. UNITED STATES STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 273. UNITED STATES STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 274. UNITED STATES STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 275. UNITED STATES STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 276. UNITED STATES STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 277. UNITED STATES STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 278. UNITED STATES STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 279. UNITED STATES STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. UNITED STATES STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 282. CANADA STEM CELL BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 283. CANADA STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 284. CANADA STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 285. CANADA STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 286. CANADA STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 287. CANADA STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 288. CANADA STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 289. CANADA STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 290. CANADA STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 291. CANADA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 292. CANADA STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 293. CANADA STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. MEXICO STEM CELL BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 295. MEXICO STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 296. MEXICO STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 297. MEXICO STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 298. MEXICO STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 299. MEXICO STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 300. MEXICO STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 301. MEXICO STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 302. MEXICO STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 303. MEXICO STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 304. MEXICO STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 305. MEXICO STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL STEM CELL BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 307. BRAZIL STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 308. BRAZIL STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 309. BRAZIL STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 310. BRAZIL STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 311. BRAZIL STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 312. BRAZIL STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 313. BRAZIL STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 314. BRAZIL STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 315. BRAZIL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 316. BRAZIL STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 317. BRAZIL STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 320. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 321. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 322. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 323. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 324. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 325. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 326. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 327. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 328. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 329. UNITED KINGDOM STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 330. GERMANY STEM CELL BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 331. GERMANY STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 332. GERMANY STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 333. GERMANY STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 334. GERMANY STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 335. GERMANY STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 336. GERMANY STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 337. GERMANY STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 338. GERMANY STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 339. GERMANY STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 340. GERMANY STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 341. GERMANY STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 342. FRANCE STEM CELL BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 343. FRANCE STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 344. FRANCE STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 345. FRANCE STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 346. FRANCE STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 347. FRANCE STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 348. FRANCE STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 349. FRANCE STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 350. FRANCE STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 351. FRANCE STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 352. FRANCE STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 353. FRANCE STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 354. RUSSIA STEM CELL BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 355. RUSSIA STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 356. RUSSIA STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 357. RUSSIA STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 358. RUSSIA STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 359. RUSSIA STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 360. RUSSIA STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 361. RUSSIA STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 362. RUSSIA STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 363. RUSSIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 364. RUSSIA STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 365. RUSSIA STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 366. ITALY STEM CELL BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 367. ITALY STEM CELL BANKING MARKET SIZE, BY TISSUE SOURCE, 2017-2032 (USD MILLION)
TABLE 368. ITALY STEM CELL BANKING MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 369. ITALY STEM CELL BANKING MARKET SIZE, BY SERVICE TYPE, 2017-2032 (USD MILLION)
TABLE 370. ITALY STEM CELL BANKING MARKET SIZE, BY COLLECTION, 2017-2032 (USD MILLION)
TABLE 371. ITALY STEM CELL BANKING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 372. ITALY STEM CELL BANKING MARKET SIZE, BY PROCESSING, 2017-2032 (USD MILLION)
TABLE 373. ITALY STEM CELL BANKING MARKET SIZE, BY STORAGE, 2017-2032 (USD MILLION)
TABLE 374. ITALY STEM CELL BANKING MARKET SIZE, BY THAWING, 2017-2032 (USD MILLION)
TABLE 375. ITALY STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 376. ITALY STEM CELL BANKING MARKET SIZE, BY OWNERSHIP MODEL, 2017-2032 (USD MILLION)
TABLE 377. ITALY STEM CELL BANKING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 378. SPAIN STEM CELL BANKING MARKET SIZE, 2017-2032 (USD MILLION)
TABL

Companies Mentioned

  • America Cell Bank
  • Amgen Inc.
  • AstraZeneca PLC
  • BeiGene, Ltd.
  • Bio-Techne Corporation
  • BIONET Corp.
  • BioVault Technical Ltd.
  • Cellaviva AB
  • Celularity Inc.
  • Cordlife Group Limited
  • Cryoviva Biotech India Pvt. Ltd.
  • FamiCord Group
  • Gilead Sciences, Inc.
  • Global Cord Blood Corporation
  • LifeCell International Pvt. Ltd.
  • Macopharma SA
  • Pharmicell Co., Ltd.
  • Ree Laboratories Pvt. Ltd.
  • Sanofi S.A.
  • STARLIMS Corporation
  • StemCell Institute, Inc.
  • StemCord Private Ltd.
  • StemCyte India Therapeutics Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
  • ThermoGenesis Holdings, Inc.
  • Vertex Pharmaceuticals Incorporated
  • Viacord, Inc.
  • Vita 34 AG

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.22 Billion
Forecasted Market Value ( USD ) by 2032 $ 19.74 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Cell Banking Outsourcing Market - Global Forecast 2026-2032 - Product Image

Cell Banking Outsourcing Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Cell Banking Outsourcing - Global Strategic Business Report - Product Image

Cell Banking Outsourcing - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
Stem Cell Banking Market Report by Product Type, Service Type, Bank Type, Utilization, Application, and Region 2026-2034 - Product Image

Stem Cell Banking Market Report by Product Type, Service Type, Bank Type, Utilization, Application, and Region 2026-2034

  • Report
  • 148 Pages
  • Global
From
Stem Cell Banking - Global Strategic Business Report - Product Image

Stem Cell Banking - Global Strategic Business Report

  • Report
  • 289 Pages
  • Global
From
GMP Cell Banking Services Market - Global Forecast 2025-2032 - Product Image

GMP Cell Banking Services Market - Global Forecast 2025-2032

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.